PWMG
ANGO icon

Prestige Wealth Management Group’s AngioDynamics ANGO Stock Holding History

Prestige Wealth Management Group’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-118
Closed -$863 – 1025
2023
Q3 		$863 Hold
118
– – ﹤0.01% 896
2023
Q2 		$1.23K Buy
+118
New +$1.14K ﹤0.01% 871

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Prestige Wealth Management Group's ANGO Position: Q4 2023 in Review

Prestige Wealth Management Group sold out of AngioDynamics (ANGO) in Q4 2023, closing a stake of 118 shares — an estimated $863 sold.

Prestige Wealth Management Group first reported a position in ANGO in Q2 2023 and held it in 2 quarters. The position peaked at $1.23K in Q2 2023. 150 funds tracked by Wall St. Rank hold ANGO as of Q4 2023.

  • Prestige Wealth Management Group reported no remaining AngioDynamics position as of Q4 2023 after selling out during the quarter.
  • Prestige Wealth Management Group sold 118 AngioDynamics shares in Q4 2023, an estimated $863.
  • Prestige Wealth Management Group first reported a position in AngioDynamics in Q2 2023 and held it in 2 quarters.
  • Prestige Wealth Management Group's AngioDynamics position peaked at $1.23K in Q2 2023.
  • 150 funds tracked by Wall St. Rank held AngioDynamics as of Q4 2023.

Based on Prestige Wealth Management Group's 13F filing for Q4 2023, filed 8 Feb 2024.